In the context of a patient case presentation, expert faculty will highlight the stages of Alzheimer disease (AD) and the vital importance of early detection of mild cognitive impairment (MCI). They will discuss screening for MCI and current guidelines and standards of care for establishing a diagnosis of AD. The faculty will also examine the effects of increasingly more accessible neuroimaging and fluid markers on the diagnosis of AD, especially with the recent FDA approvals of anti-amyloid therapies.